Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Loap

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2024
Proton therapy reduces the effective dose to immune cells in breast cancer patientsPierre Loap, Jeremi Vu-Bezin, Ludovic De Marzi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2024
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case reportPierre Loap, Natacha Johnson, Rudy Birsen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2025
Genomic analysis of radiosensitivity in breast cancer : Identifying pathological determinants and assessing genomic-adjusted radiation dose (GARD) for personalized dose escalationPierre Loap, Irène Buvat, Alain Fourquet, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 27, 2024
Determinants of radiation dose to immune cells during breast radiotherapyPierre Loap, Jeremi Vu Bezin, Ludovic De Marzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2020
Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapyPierre Loap, Nicolas Tkatchenko, Eliot Nicolas, et al.
The Breast Journal|July 1, 2021
Five-year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breastPierre Loap, Fatima Laki, Philippe Beuzeboc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 25, 2024
Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approachJihane Bouziane, Pierre Loap, Kim Cao, et al.
Practical Radiation Oncology|February 9, 2021
A Radiation Therapy Contouring Atlas for Cardiac Conduction Node DelineationPierre Loap, Vincent Servois, Gilles Dhonneur, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 18, 2025
Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experienceJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2025
Exposure to the immune system during bridging radiotherapy for Car-T cellsPierre Loap, Justine Decroocq, Rudy Birsen, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 26, 2024
Proton therapy reduces the effective dose to immune cells in breast cancer patientsPierre Loap, Jeremi Vu-Bezin, Ludovic De Marzi, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|July 2, 2024
Tolerance of radiotherapy with concomitant glofitamab in diffuse large B cell lymphoma: a case reportPierre Loap, Natacha Johnson, Rudy Birsen, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 29, 2025
Genomic analysis of radiosensitivity in breast cancer : Identifying pathological determinants and assessing genomic-adjusted radiation dose (GARD) for personalized dose escalationPierre Loap, Irène Buvat, Alain Fourquet, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 27, 2024
Determinants of radiation dose to immune cells during breast radiotherapyPierre Loap, Jeremi Vu Bezin, Ludovic De Marzi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 2, 2020
Optimization and auto-segmentation of a high risk cardiac zone for heart sparing in breast cancer radiotherapyPierre Loap, Nicolas Tkatchenko, Eliot Nicolas, et al.
The Breast Journal|July 1, 2021
Five-year outcomes in patients treated with surgery and radiotherapy for primary neuroendocrine neoplasm of the breastPierre Loap, Fatima Laki, Philippe Beuzeboc, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 25, 2024
Evolution of breast cancer management after mediastinal hodgkin lymphoma: Towards a breast- conserving approachJihane Bouziane, Pierre Loap, Kim Cao, et al.
Practical Radiation Oncology|February 9, 2021
A Radiation Therapy Contouring Atlas for Cardiac Conduction Node DelineationPierre Loap, Vincent Servois, Gilles Dhonneur, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 18, 2025
Ultra hypofractionated breast radiotherapy according to the Fast-Forward scheme: Excellent early tolerance or delayed skin reactions? Real life experienceJihane Bouziane, Pierre Loap, Sofiane Allali, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|April 20, 2025
Exposure to the immune system during bridging radiotherapy for Car-T cellsPierre Loap, Justine Decroocq, Rudy Birsen, et al.
Pageof 12